UCB's Global Corporate Website

Two more ventures join UCB’s Digital Care Transformation (DCTx) Incubator

Posted by
Thyago Ohana, Digital Care Transformation Immunology

Our Digital Care Transformation team is delighted to announce two new participants going into the DCTx Incubator. 

We strongly believe these ventures could each have a major impact on global healthcare, and we are excited to take these steps on their journey together. 

Voice technology that can act as a biomarker of disease 

PeakProfiling combines voice analytics based on quantitative musicology of sound patterns with Machine Learning methods. Several clinical studies have already demonstrated that this technology can serve as a valid predictor of certain clinical conditions. 

Julia Amunts of PeakProfiling “Working alongside the team of UCB will support us in validating our voice technology that can potentially act as a biomarker for a wide range of diseases. This collaboration entirely fits in our mission of developing individualised digital solutions to support the patients' journey from early diagnosis to disease monitoring.” 

Delivering accessible, drug-free, digital wellness through Virtual Reality (VR) based technology 

VRx Medical is an immersive digital therapeutics company founded in California by Garland Wong and Paul Lafferty. Their mission is to deliver accessible, drug-free, digital wellness through immersive VR technology. 

Bringing together virtual and augmented reality to the fingertips of patients, providing a wide range of therapies that can integrate into their lifestyles. 

Garland of VRx Medical comments "VRx Medical is proud and excited to work with the team at UCB. Together, we hope to optimize our digital therapeutic designed to improve the quality of life for patients suffering from chronic pain”. 

To find out more about our incubator and to apply to be a part of the program, please visit our website on UCB-DCTx.com - alternatively, you can contact us via email on contact@ucb-dctx.com.


Leave a Comment

By submitting your personal data, you agree with UCB's Data Privacy Policy. Furthermore, for more information on the terms of use of this website please visit our Legal Notice, accessible here.


Enter the characters shown in the image.